SFI
PROK icon

Susquehanna Fundamental Investments’s ProKidney PROK Stock Holding History

Susquehanna Fundamental Investments’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44,707
Closed -$39.2K – 950
2025
Q1 		$39.2K Sell
44,707
-7,421
-14% -$10.3K ﹤0.01% 1045
2024
Q4 		$88.1K Buy
+52,128
New +$94K ﹤0.01% 1043
2024
Q2 		$106K Buy
+42,990
New +$115K ﹤0.01% 892

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BU
Brown University Providence, Rhode Island $102M AUM 26.79% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna Fundamental Investments's PROK Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of ProKidney (PROK) in Q2 2025, closing a stake of 44,707 shares — an estimated $39.2K sold.

Susquehanna Fundamental Investments first reported a position in PROK in Q2 2024 and held it in 3 quarters. The position peaked at $106K in Q2 2024. 56 funds tracked by Wall St. Rank hold PROK as of Q2 2025.

  • Susquehanna Fundamental Investments reported no remaining ProKidney position as of Q2 2025 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 44,707 ProKidney shares in Q2 2025, an estimated $39.2K.
  • Susquehanna Fundamental Investments first reported a position in ProKidney in Q2 2024 and held it in 3 quarters.
  • Susquehanna Fundamental Investments's ProKidney position peaked at $106K in Q2 2024.
  • 56 funds tracked by Wall St. Rank held ProKidney as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.